Healthcare Global
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Aug 26 (Reuters) - Swedish healthcare provider Medicover's MCOVb.ST India business is on track to have all 25 hospitals in its network become profitable within 18 months, driven by rising occupancy and demand for specialised care, a top executive told Reuters on Wednesday.
Earlier this month, global investment firm KKR KKR.N signed a deal to buy Medicover's India business for €1.2 billion ($1.40 billion), pending regulatory approvals.
($1 = 0.8573 euros)
(Reporting by Rishika Sadam and Kashish Tandon; Editing by Janane Venkatraman)
(([email protected]; 8800437922;))
Aug 26 (Reuters) - Swedish healthcare provider Medicover's MCOVb.ST India business is on track to have all 25 hospitals in its network become profitable within 18 months, driven by rising occupancy and demand for specialised care, a top executive told Reuters on Wednesday.
Earlier this month, global investment firm KKR KKR.N signed a deal to buy Medicover's India business for €1.2 billion ($1.40 billion), pending regulatory approvals.
($1 = 0.8573 euros)
(Reporting by Rishika Sadam and Kashish Tandon; Editing by Janane Venkatraman)
(([email protected]; 8800437922;))
Aug 6 (Reuters) - Healthcare Global Enterprises Limited HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LIMITED JUNE-QUARTER CONSOL NET PROFIT 137.7 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LIMITED JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.93 BILLION RUPEES
Further company coverage: HEAC.NS
(([email protected];))
Aug 6 (Reuters) - Healthcare Global Enterprises Limited HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LIMITED JUNE-QUARTER CONSOL NET PROFIT 137.7 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LIMITED JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.93 BILLION RUPEES
Further company coverage: HEAC.NS
(([email protected];))
Aug 4 (Reuters) - Healthcare Global Enterprises Limited HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - TO ACQUIRE 26% EQUITY STAKE IN EPIC VIGHNAHARTA RENEWABLE ENERGY FOR 3.8 MILLION RUPEES
Source text: [ID:]
Further company coverage: HEAC.NS
(([email protected];;))
Aug 4 (Reuters) - Healthcare Global Enterprises Limited HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - TO ACQUIRE 26% EQUITY STAKE IN EPIC VIGHNAHARTA RENEWABLE ENERGY FOR 3.8 MILLION RUPEES
Source text: [ID:]
Further company coverage: HEAC.NS
(([email protected];;))
May 19 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES - LAUNCHES CANCER HOSPITAL WITH UP TO 132 BEDS IN HEBBAL, BENGALURU
Source text: ID:nBSE4ngg11
Further company coverage: HEAC.NS
(([email protected];))
May 19 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES - LAUNCHES CANCER HOSPITAL WITH UP TO 132 BEDS IN HEBBAL, BENGALURU
Source text: ID:nBSE4ngg11
Further company coverage: HEAC.NS
(([email protected];))
Feb 24 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
RIGHTS ISSUE UP TO 4.25 BILLION RUPEES APPROVED
RIGHTS ISSUE PRICE AT 512 RUPEES/SHARE, RATIO IS 1 SHARE FOR EVERY 17 SHARES
Source text: ID:nBSE4jylYH
Further company coverage: HEAC.NS
(([email protected];;))
Feb 24 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
RIGHTS ISSUE UP TO 4.25 BILLION RUPEES APPROVED
RIGHTS ISSUE PRICE AT 512 RUPEES/SHARE, RATIO IS 1 SHARE FOR EVERY 17 SHARES
Source text: ID:nBSE4jylYH
Further company coverage: HEAC.NS
(([email protected];;))
Feb 17 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - APPROVES EQUITY SHARES ISSUANCE FOR 4.25 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LTD - ISSUANCE OF EQUITY SHARES VIA RIGHTS ISSUE
Source text: ID:nBSE3c7jHs
Further company coverage: HEAC.NS
(([email protected];;))
Feb 17 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - APPROVES EQUITY SHARES ISSUANCE FOR 4.25 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LTD - ISSUANCE OF EQUITY SHARES VIA RIGHTS ISSUE
Source text: ID:nBSE3c7jHs
Further company coverage: HEAC.NS
(([email protected];;))
** Investment by U.S. private equity firm KKR KKR.N to acquire controlling stake in Healthcare Global Enterprises HEAC.NS will bring in more operational, financial efficiency, PL Capital says
** Brokerage raises HEAC's PT to 555 rupees from 535 rupees, maintains "buy" rating
** Expects KKR to drive growth in the cancer care provider through bed expansion, assets' rationalization, margins expansion
** Co's asset-light approach with focus on partnerships has made its model more capital efficient, scalable, PL Capital says
** Stock last down 1.5% amid broader market rout
(Reporting by Aleef Jahan in Bengaluru)
** Investment by U.S. private equity firm KKR KKR.N to acquire controlling stake in Healthcare Global Enterprises HEAC.NS will bring in more operational, financial efficiency, PL Capital says
** Brokerage raises HEAC's PT to 555 rupees from 535 rupees, maintains "buy" rating
** Expects KKR to drive growth in the cancer care provider through bed expansion, assets' rationalization, margins expansion
** Co's asset-light approach with focus on partnerships has made its model more capital efficient, scalable, PL Capital says
** Stock last down 1.5% amid broader market rout
(Reporting by Aleef Jahan in Bengaluru)
** Shares of Healthcare Global Enterprises HEAC.NS rise 3.5% to 517 rupees
** The healthcare services provider said U.S. private equity firm KKR to acquire controlling stake in co for $400 million
** KKR will initially acquire a 51% stake in HEAC, with an option to purchase an additional 3% if its open offer for a further 26% stake is unsuccessful
** More than 374,000 shares change hands, 1.3x its 30-day avg
** Five analysts covering the stock on avg have a "buy" rating; median PT is 546 rupees - LSEG data
** Healthcare Global stock has gained 4% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Healthcare Global Enterprises HEAC.NS rise 3.5% to 517 rupees
** The healthcare services provider said U.S. private equity firm KKR to acquire controlling stake in co for $400 million
** KKR will initially acquire a 51% stake in HEAC, with an option to purchase an additional 3% if its open offer for a further 26% stake is unsuccessful
** More than 374,000 shares change hands, 1.3x its 30-day avg
** Five analysts covering the stock on avg have a "buy" rating; median PT is 546 rupees - LSEG data
** Healthcare Global stock has gained 4% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
-- Source link: https://tinyurl.com/bdz39327
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
-- Source link: https://tinyurl.com/bdz39327
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
July 2 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES- ACQUISITION OF SHARES OF VIZAG HOSPITAL AND CANCER RESEARCH CENTRE
HEALTHCARE GLOBAL ENTERPRISES LTD- COST OF ACQUISITION OF 51% STAKE AT 2.08 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES- COST OF ACQUISITION OF ADDITIONAL 34% STAKE AT 1.55 BILLION RUPEES
Source text for Eikon: ID:nBSE4bgLbx
Further company coverage: HEAC.NS
(([email protected];))
July 2 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES- ACQUISITION OF SHARES OF VIZAG HOSPITAL AND CANCER RESEARCH CENTRE
HEALTHCARE GLOBAL ENTERPRISES LTD- COST OF ACQUISITION OF 51% STAKE AT 2.08 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES- COST OF ACQUISITION OF ADDITIONAL 34% STAKE AT 1.55 BILLION RUPEES
Source text for Eikon: ID:nBSE4bgLbx
Further company coverage: HEAC.NS
(([email protected];))
June 28 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD -ENTERED INTO AGREEMENT WITH VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES - CO HAS AGREED UNDER PROVISIONS OF SPA TO ACQUIRE 51% OF EQUITY SHARE CAPITAL IN VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES LTD - CO WILL ACQUIRE BALANCE 49% STAKE IN VIZAG HOSPITAL IN TRANCHES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF 51% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 2.08 BLN RUPEES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF ADDITIONAL 34% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 1.56 BLN RUPEES
Source text for Eikon: [ID:]
Further company coverage: HEAC.NS
(([email protected];))
June 28 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD -ENTERED INTO AGREEMENT WITH VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES - CO HAS AGREED UNDER PROVISIONS OF SPA TO ACQUIRE 51% OF EQUITY SHARE CAPITAL IN VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES LTD - CO WILL ACQUIRE BALANCE 49% STAKE IN VIZAG HOSPITAL IN TRANCHES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF 51% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 2.08 BLN RUPEES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF ADDITIONAL 34% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 1.56 BLN RUPEES
Source text for Eikon: [ID:]
Further company coverage: HEAC.NS
(([email protected];))
-- Source link: https://bit.ly/3I0Bjz3
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
-- Source link: https://bit.ly/3I0Bjz3
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
Nov 9 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL NET PROFIT 135.7 MILLION RUPEES VERSUS 73.8 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.86 BILLION RUPEES VERSUS 4.19 BILLION RUPEES
Source text for Eikon: ID:nBSEbngsxM
Further company coverage: HEAC.NS
(([email protected];))
Nov 9 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL NET PROFIT 135.7 MILLION RUPEES VERSUS 73.8 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.86 BILLION RUPEES VERSUS 4.19 BILLION RUPEES
Source text for Eikon: ID:nBSEbngsxM
Further company coverage: HEAC.NS
(([email protected];))
Nov 8 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - DECIDED NOT TO PURSUE BTA ARRANGEMENT WITH RADIANT HOSPITAL SERVICES
HEALTHCARE GLOBAL ENTERPRISES LTD - CO EXPLORING OTHER FEASIBLE OPTIONS, FOR OPERATING CANCER CENTRE IN SAMBALPUR
Source text for Eikon: ID:nNSEbLYGCL
Further company coverage: HEAC.NS
(([email protected];))
Nov 8 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - DECIDED NOT TO PURSUE BTA ARRANGEMENT WITH RADIANT HOSPITAL SERVICES
HEALTHCARE GLOBAL ENTERPRISES LTD - CO EXPLORING OTHER FEASIBLE OPTIONS, FOR OPERATING CANCER CENTRE IN SAMBALPUR
Source text for Eikon: ID:nNSEbLYGCL
Further company coverage: HEAC.NS
(([email protected];))
BENGALURU, Sept 26 (Reuters) - Private equity firm CVC Capital Partners is considering to sell 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises HEAC.NS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
(Reporting by Kashish Tandon in Bengaluru; Editing by Shinjini Ganguli)
(([email protected];))
BENGALURU, Sept 26 (Reuters) - Private equity firm CVC Capital Partners is considering to sell 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises HEAC.NS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
(Reporting by Kashish Tandon in Bengaluru; Editing by Shinjini Ganguli)
(([email protected];))
Aug 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
SRINIVASA V. RAGHAVAN WILL CEASE TO BE CFO EFFECTIVE AUG 20
NAMES RUBY RITOLIA AS CFO
Source text for Eikon: ID:nNSE7551bL
Further company coverage: HEAC.NS
(([email protected];))
Aug 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
SRINIVASA V. RAGHAVAN WILL CEASE TO BE CFO EFFECTIVE AUG 20
NAMES RUBY RITOLIA AS CFO
Source text for Eikon: ID:nNSE7551bL
Further company coverage: HEAC.NS
(([email protected];))
July 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - NAGPUR CANCER HOSPITAL & RESEARCH INSTITUTE, CO AND HCG NCHRI LLP ENTERED INTO A PARTNERSHIP TRANSFER AGREEMENT
Source text for Eikon: ID:nBSE1mMJC5
Further company coverage: HEAC.NS
(([email protected];))
July 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - NAGPUR CANCER HOSPITAL & RESEARCH INSTITUTE, CO AND HCG NCHRI LLP ENTERED INTO A PARTNERSHIP TRANSFER AGREEMENT
Source text for Eikon: ID:nBSE1mMJC5
Further company coverage: HEAC.NS
(([email protected];))
July 6 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CO ENTERED INTO SHARE PURCHASE AGREEMENT WITH SHAREHOLDERS OF NCHRI FOR ACQUIRING ENTIRE STAKE IN NCHRI
COST OF ACQUISITION OF ENTIRE SHARES IN NCHRI WOULD BE 141 MILLION RUPEES
Source text for Eikon: ID:nNSE8nKZ5V
Further company coverage: HEAC.NS
(([email protected];;))
July 6 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CO ENTERED INTO SHARE PURCHASE AGREEMENT WITH SHAREHOLDERS OF NCHRI FOR ACQUIRING ENTIRE STAKE IN NCHRI
COST OF ACQUISITION OF ENTIRE SHARES IN NCHRI WOULD BE 141 MILLION RUPEES
Source text for Eikon: ID:nNSE8nKZ5V
Further company coverage: HEAC.NS
(([email protected];;))
** Shares of Healthcare Global Enterprises Ltd HEAC.NS rise as much as 3.49% to 304 rupees
** Uptick after co, which provides cancer care services, says it is considering potential inorganic restructuring of its operations in Nagpur city
** HEAC to consider increasing its stake in HCG NCHRI Oncology LLP
** Also evaluating greenfield and brownfield opportunities in Madhya Pradesh state
** Trading volume is 128,178 shares as of 12:40 p.m. IST, 1.1x the 30-day avg - Refinitiv data
** All eight analysts tracking HEAC maintain "buy"; median PT is 375 rupees
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
** Shares of Healthcare Global Enterprises Ltd HEAC.NS rise as much as 3.49% to 304 rupees
** Uptick after co, which provides cancer care services, says it is considering potential inorganic restructuring of its operations in Nagpur city
** HEAC to consider increasing its stake in HCG NCHRI Oncology LLP
** Also evaluating greenfield and brownfield opportunities in Madhya Pradesh state
** Trading volume is 128,178 shares as of 12:40 p.m. IST, 1.1x the 30-day avg - Refinitiv data
** All eight analysts tracking HEAC maintain "buy"; median PT is 375 rupees
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
May 25 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL NET PROFIT 83.7 MILLION RUPEES VERSUS 59.9 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.41 BILLION RUPEES VERSUS 3.64 BILLION RUPEES
Source text for Eikon: ID:nBSE9ff4wn
Further company coverage: HEAC.NS
(([email protected];))
May 25 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL NET PROFIT 83.7 MILLION RUPEES VERSUS 59.9 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.41 BILLION RUPEES VERSUS 3.64 BILLION RUPEES
Source text for Eikon: ID:nBSE9ff4wn
Further company coverage: HEAC.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Healthcare Global do?
HealthCare Global Enterprises Ltd (HCG) is India's largest provider of cancer care with a network of comprehensive cancer centers. They also own fertility centers under the brand 'Milann', leading in specialist tertiary healthcare.
Who are the competitors of Healthcare Global?
Healthcare Global major competitors are Yatharth Hospital, Jupiter Life Line, Kovai Medical Center, RainbowChildrenS Med, Artemis MedicareServ, Indraprastha Medical, Dr Agarwals Eye Hosp. Market Cap of Healthcare Global is ₹10,095 Crs. While the median market cap of its peers are ₹6,627 Crs.
Is Healthcare Global financially stable compared to its competitors?
Healthcare Global seems to be less financially stable compared to its competitors. Altman Z score of Healthcare Global is 3.67 and is ranked 8 out of its 8 competitors.
Does Healthcare Global pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Healthcare Global latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Healthcare Global allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Healthcare Global balance sheet?
Balance sheet of Healthcare Global is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Healthcare Global improving?
The profit is oscillating. The profit of Healthcare Global is ₹31.55 Crs for TTM, ₹13.76 Crs for Mar 2026 and ₹44.41 Crs for Mar 2025.
Is the debt of Healthcare Global increasing or decreasing?
The net debt of Healthcare Global is decreasing. Latest net debt of Healthcare Global is -₹169.19 Crs as of Mar-26. This is less than Mar-25 when it was ₹310 Crs.
Is Healthcare Global stock expensive?
Yes, Healthcare Global is expensive. Latest PE of Healthcare Global is 442, while 3 year average PE is 182. Also latest EV/EBITDA of Healthcare Global is 21.76 while 3yr average is 18.75.
Has the share price of Healthcare Global grown faster than its competition?
Healthcare Global has given better returns compared to its competitors. Healthcare Global has grown at ~28.47% over the last 2yrs while peers have grown at a median rate of 5.2%
Is the promoter bullish about Healthcare Global?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Healthcare Global is 64.21% and last quarter promoter holding is 64.21%.
Are mutual funds buying/selling Healthcare Global?
The mutual fund holding of Healthcare Global is increasing. The current mutual fund holding in Healthcare Global is 15.43% while previous quarter holding is 15.31%.